Published in JMIR Mhealth Uhealth on February 01, 2016
Apps for People With Rheumatoid Arthritis to Monitor Their Disease Activity: A Review of Apps for Best Practice and Quality. JMIR Mhealth Uhealth (2017) 0.75
Monitoring-Based Model for Personalizing the Clinical Process of Crohn's Disease. Sensors (Basel) (2017) 0.75
Pediatric Patient and Caregiver Preferences in the Development of a Mobile Health Application for Management of Surgical Colorectal Conditions. J Med Syst (2017) 0.75
Using the internet to promote health behavior change: a systematic review and meta-analysis of the impact of theoretical basis, use of behavior change techniques, and mode of delivery on efficacy. J Med Internet Res (2010) 10.12
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management. J Crohns Colitis (2010) 6.75
Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol (2010) 5.20
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis. J Crohns Colitis (2010) 3.97
Management of Crohn's disease in adults. Am J Gastroenterol (2009) 3.94
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management. J Crohns Colitis (2012) 3.69
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations. J Crohns Colitis (2009) 3.66
Colorectal smartphone apps: opportunities and risks. Colorectal Dis (2012) 3.55
A behavior change model for internet interventions. Ann Behav Med (2009) 3.53
Maintaining stable symptom control in inflammatory bowel disease: a retrospective analysis of adherence, medication switches and the risk of relapse. Aliment Pharmacol Ther (2013) 3.32
Smartphone medication adherence apps: potential benefits to patients and providers. J Am Pharm Assoc (2003) (2013) 3.13
Mobile app rating scale: a new tool for assessing the quality of health mobile apps. JMIR Mhealth Uhealth (2015) 2.60
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. J Crohns Colitis (2012) 2.55
Medical apps for smartphones: lack of evidence undermines quality and safety. Evid Based Med (2012) 2.15
eHealth: individualization of mesalazine treatment through a self-managed web-based solution in mild-to-moderate ulcerative colitis. Inflamm Bowel Dis (2014) 2.02
Factors associated with non-adherence to oral medication for inflammatory bowel disease: a systematic review. Am J Gastroenterol (2009) 1.84
Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Gut (2004) 1.77
Diabetes self-management smartphone application for adults with type 1 diabetes: randomized controlled trial. J Med Internet Res (2013) 1.76
The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. Am J Gastroenterol (2008) 1.72
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis (2012) 1.71
Potential use of telemedicine to provide outpatient care for inflammatory bowel disease. Am J Gastroenterol (2011) 1.57
Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort. Gut (2005) 1.26
E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided 'Constant-care' approach. Gut (2010) 1.22
The evolution of mobile apps for asthma: an updated systematic assessment of content and tools. BMC Med (2015) 1.21
The effect of reminder systems on patients' adherence to treatment. Patient Prefer Adherence (2012) 1.19
Medication-taking behavior in a cohort of patients with inflammatory bowel disease. Dig Dis Sci (2006) 1.19
Feasibility and acceptance of a home telemanagement system in patients with inflammatory bowel disease: a 6-month pilot study. Dig Dis Sci (2007) 1.16
Mobile phone health apps for diabetes management: current evidence and future developments. QJM (2013) 1.11
Self-management for people with inflammatory bowel disease. Can J Gastroenterol (2008) 1.09
Commercially available mobile phone headache diary apps: a systematic review. JMIR Mhealth Uhealth (2014) 1.06
Using instructional design process to improve design and development of Internet interventions. J Med Internet Res (2012) 1.03
Need to peer-review medical applications for smart phones. J Telemed Telecare (2012) 1.02
Telehealth behavioral treatment for medication nonadherence: a pilot and feasibility study. Eur J Gastroenterol Hepatol (2013) 0.98
Ulcerative colitis: no rise in mortality in a European-wide population based cohort 10 years after diagnosis. Gut (2006) 0.95
Randomized, controlled trial of home telemanagement in patients with ulcerative colitis (UC HAT). Inflamm Bowel Dis (2011) 0.94
Practical strategies for enhancing adherence to treatment regimen in inflammatory bowel disease. Inflamm Bowel Dis (2013) 0.94
DialBetics: smartphone-based self-management for type 2 diabetes patients. J Diabetes Sci Technol (2012) 0.92
Dose-response effects of the text4baby mobile health program: randomized controlled trial. JMIR Mhealth Uhealth (2015) 0.91
Mobile phone-based asthma self-management aid for adolescents (mASMAA): a feasibility study. Patient Prefer Adherence (2014) 0.91
Dietary and nutritional considerations for inflammatory bowel disease. Proc Nutr Soc (2011) 0.90
Effects of and satisfaction with short message service reminders for patient medication adherence: a randomized controlled study. BMC Med Inform Decis Mak (2013) 0.90
Development of a Web-based concept for patients with ulcerative colitis and 5-aminosalicylic acid treatment. Eur J Gastroenterol Hepatol (2010) 0.90
An investigation of medication adherence to 5-aminosalicylic acid therapy in patients with ulcerative colitis, using self-report and urinary drug excretion measurements. Aliment Pharmacol Ther (2009) 0.88
Fatty acids, IL6, and TNFalpha polymorphisms: an example of nutrigenetics in Crohn's disease. Am J Gastroenterol (2009) 0.87
Volitional and accidental nonadherence to pediatric inflammatory bowel disease treatment plans: initial investigation of associations with quality of life and disease activity. J Pediatr Psychol (2010) 0.87
What do patients need to know? Living with inflammatory bowel disease. J Clin Nurs (2013) 0.85
Future perspectives of Smartphone applications for rheumatic diseases self-management. Rheumatol Int (2014) 0.84
Distance management of inflammatory bowel disease: systematic review and meta-analysis. World J Gastroenterol (2014) 0.84
Factors associated with thiopurine non-adherence in patients with inflammatory bowel disease. Aliment Pharmacol Ther (2013) 0.84
Don't Forget the Doctor: Gastroenterologists' Preferences on the Development of mHealth Tools for Inflammatory Bowel Disease. JMIR Mhealth Uhealth (2015) 0.82
Development of a Web-based, self-reporting symptom diary for Crohn's Disease, and its correlation with the Crohn's Disease Activity Index: Web-based, self-reporting symptom diary for Crohn's Disease. J Crohns Colitis (2014) 0.81
Fat intake interacts with polymorphisms of Caspase9, FasLigand and PPARgamma apoptotic genes in modulating Crohn's disease activity. Clin Nutr (2010) 0.81
Medication adherence and persistence in the treatment of Canadian ulcerative colitis patients: analyses with the RAMQ database. BMC Gastroenterol (2013) 0.81
What Are Adults With Inflammatory Bowel Disease (IBD) Eating? A Closer Look at the Dietary Habits of a Population-Based Canadian IBD Cohort. JPEN J Parenter Enteral Nutr (2014) 0.80
Non-adherence to treatment in inflammatory bowel disease in Czech Republic. J Crohns Colitis (2007) 0.79
TELEmedicine for Patients with Inflammatory Bowel Disease (TELE-IBD): Design and implementation of randomized clinical trial. Contemp Clin Trials (2015) 0.79
Trust, Perceived Risk, Perceived Ease of Use and Perceived Usefulness as Factors Related to mHealth Technology Use. Stud Health Technol Inform (2015) 0.79
Impact of the Mobile HealthPROMISE Platform on the Quality of Care and Quality of Life in Patients With Inflammatory Bowel Disease: Study Protocol of a Pragmatic Randomized Controlled Trial. JMIR Res Protoc (2015) 0.78
Moderate dietary temperance effectively prevents relapse of Crohn disease: a prospective study of patients in remission. Gastroenterol Nurs (2007) 0.78
Beliefs About GI Medications and Adherence to Pharmacotherapy in Functional GI Disorder Outpatients. Am J Gastroenterol (2015) 0.76
Infliximab dependency is related to decreased surgical rates in adult Crohn's disease patients. Eur J Gastroenterol Hepatol (2010) 0.76
Noninvasive imaging of the small bowel in Crohn's disease: the final frontier. Inflamm Bowel Dis (2011) 1.40
Serological antibodies in inflammatory bowel disease: a systematic review. Inflamm Bowel Dis (2011) 1.30
Impact of ethnicity, geography, and disease on the microbiota in health and inflammatory bowel disease. Inflamm Bowel Dis (2013) 1.00
Comparison of clinical characteristics and management of inflammatory bowel disease in Hong Kong versus Melbourne. J Gastroenterol Hepatol (2012) 0.99
Chromoendoscopy versus narrow band imaging for colonic surveillance in inflammatory bowel disease. Inflamm Bowel Dis (2013) 0.96
Practical application of anti-TNF therapy for luminal Crohn's disease. Inflamm Bowel Dis (2011) 0.88
Dysplastic lesions in ulcerative colitis: changing paradigms. Inflamm Bowel Dis (2010) 0.83
Inflammatory bowel disease serology in Asia and the West. World J Gastroenterol (2013) 0.83
Fecal biomarkers in the diagnosis and monitoring of Crohn's disease. Inflamm Bowel Dis (2014) 0.81
An Overview of the Innate and Adaptive Immune System in Inflammatory Bowel Disease. Inflamm Bowel Dis (2016) 0.77
Crohn’s disease: towards improving postsurgical outcomes. Med J Aust (2013) 0.75
Comparison of Fecal Inflammatory Markers in Crohn's Disease. Inflamm Bowel Dis (2016) 0.75
Practice corner: should we screen all patients starting chemotherapy for chronic hepatitis B virus infection? Evid Based Med (2009) 0.75